News

Avita Medical, Inc. Announces Resignation of Louis Drapeau from Board of Directors

VALENCIA, Calif. and MELBOURNE, Australia, April 21, 2022 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (Company), a…

2 years ago

Truepill Names Ana Schrank as Chief Financial Officer

SAN MATEO, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Truepill, the digital health platform connecting telehealth, diagnostics, and pharmacy infrastructure…

2 years ago

Blue Water Vaccines Presents New Data Supporting Universal Influenza Vaccine Candidate at the World Vaccine Congress 2022 in Washington, DC

CINCINNATI, April 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a…

2 years ago

Homology Medicines Announces Promotion of Albert Seymour, Ph.D., to President

BEDFORD, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that…

2 years ago

G1 Therapeutics to Release First Quarter 2022 Financial Results and Provide Business Update on May 4, 2022

RESEARCH TRIANGLE PARK, N.C., April 21, 2022 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, will…

2 years ago

Mustang Bio Announces Upcoming MB-106 CD20-Targeted CAR T Data Presentations

Fred Hutch’s Dr. Mazyar Shadman to present data on Mustang’s autologous CAR T-cell therapy for the treatment of B-cell non-Hodgkin…

2 years ago

WIMI Hologram Academy: The Application of Virtual Reality in the inheritance and protection of Intangible Cultural Heritage

HONG KONG, April 21, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

2 years ago

AIM ImmunoTech Provides Summary of Ampligen® Data Supporting Synergistic Potential with Checkpoint Blockade Therapies

Robert Edwards, MD Robert Edwards, MD Michael (Tony) Hollingsworth, PhD Michael (Tony) Hollingsworth, PhD Pawel Kalinski, MD, PhD Pawel Kalinski,…

2 years ago

Spero Therapeutics to Present Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases

CAMBRIDGE, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced two oral presentations and four poster…

2 years ago

Aveanna Announces First Quarter 2022 Earnings Release Date and Conference Call

ATLANTA, April 21, 2022 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will…

2 years ago